van der Heijde, D., Dijkmans, B., Schiff, M., Kivitz, A., de Vlam, K., Wordsworth, P., . . . Grp, A. (2008). Maintenance of reduction in disease activity and partial remission in patients with Ankylosing spondylitis (AS) - 3-year results from the adalimumab (HUMIRO) trial evaluating long-term efficacy and safety in AS (ATLAS).
Lua i Stíl Chicago (17ú heag.)van der Heijde, D., et al. Maintenance of Reduction in Disease Activity and Partial Remission in Patients with Ankylosing Spondylitis (AS) - 3-year Results from the Adalimumab (HUMIRO) Trial Evaluating Long-term Efficacy and Safety in AS (ATLAS). 2008.
Lua MLA (9ú heag.)van der Heijde, D., et al. Maintenance of Reduction in Disease Activity and Partial Remission in Patients with Ankylosing Spondylitis (AS) - 3-year Results from the Adalimumab (HUMIRO) Trial Evaluating Long-term Efficacy and Safety in AS (ATLAS). 2008.